Halting tuberculosis' stubborn ascent
Josephine Clark-Curtiss, a researcher at the Biodesign Institute's Center for Infectious Diseases and Vaccinology. Credit: The Biodesign Institute at Arizona State University
(Medical Xpress) -- Tuberculosis is an old foe. A 500,000-year-old human fossil discovered in Turkey bears telltale signs of the disease, which today continues to wreak havoc, killing an estimated 2 million per year, according to the World Health Organization.
Josephine Clark-Curtiss, a researcher at Arizona State Universitys Biodesign Institute has been exploring new lines of attack against Mycobacterium tuberculosis, causative agent of tuberculosis. In work carried out at the Institutes Center for Infectious Diseases and Vaccinology, under the directorship of her husband, Roy Curtiss III, a new class of vaccine candidates is being investigated.
Recently, Clark-Curtiss and her colleagues have demonstrated the effectiveness of several recombinant attenuated Salmonella vaccine (or RASV) strains in two studies appearing in the journal Infection and Immunity. The teams results underline the promise of new vaccines against the disease that provide better protection than immunization with Mycobacterium bovis Bacillus Calmette-Guérin BCG the currently available vaccine along with improved practicality, flexibility of use, and importantly, cost.
Tuberculosis is one of the three leading infectious diseases, (along with malaria and AIDS), classified as serious global health threats. While advances in the developed world have been largely effective in combatting tuberculosis, once a major killer in the US and Europe, the pace of new TB cases in much of the developing world continues on a frightening upswing.
M. tuberculosis is responsible for more deaths than any other single bacterial pathogen and its occurrence in conjunction with other deadly microbes particularly the HIV virus has cut a broad swath of destruction through many regions of the globe whose medical resources are ill-equipped to deal with the flood of cases. In 2009 alone, the World Health Organization reported 9.4 million new cases of the disease, and notes that roughly one third of the worlds population has been infected with M. tuberculosis.
Carriers of the bacteria are vulnerable to developing the disease should their immune systems become compromised due to age, poor nutrition or some medical condition. Prior to this, the bacteria are able to persist in the body in a non-replicating state of dormancy for years at a time.
Four standard first-line drugs are usually used to treat the illness, though multi-drug resistant strains of M. tuberculosis are becoming more prevalent, and recent years have seen the emergence of extensively drug-resistant M. tuberculosis (XDR-TB) strains resistant to essentially all anti-TB drugs.
A more thorough understanding of tuberculosis is essential for the formulation of better therapeutics to treat the disease and more effective protective vaccines.
Recombinant attenuated Salmonella vaccines (RASV) hold much promise in the fight against a range of deadly diseases, including hepatitis B, cholera, typhoid fever, AIDS and pneumonia. To formulate such vaccines, Salmonella bacteria are modified, eliminating the virulence factors associated with their notorious disease-causing abilities and outfitting them with key protein antigens from the pathogen to be vaccinated against.
Genes encoding bacterial, viral, tumor or parasitic antigens may be inserted into Salmonella, making the bacterium a particularly versatile vaccine vector. Such RASV strains can be manufactured at low cost, do not require refrigeration during distribution and are delivered orally huge advantages, particularly in the developing world.
While other types of pathogens have been similarly applied as cargo vessels to carry disease antigens for vaccination, Salmonella is particularly well-suited for the purpose. Ingestion of the Salmonella-based vaccine stimulates all three branches of the immune response, conferring mucosal, humoral and cellular immunity, following colonization of the intestinal tract, lymph nodes, liver and spleen.
The Curtiss group has fine-tuned various versions of RASV systems, increasing their safety, efficacy, tolerability and immunogenicity. Through clever genetic manipulation, the attenuation, antigen synthesis and lysis of the Salmonella vector can be precisely controlled, significantly improving the vaccines effectiveness.
Delaying Salmonella attenuation ensures that the bacterium elicits a robust, system-wide immune response before its virulence falls off. Synthesis of the disease antigen is also tightly controlled temporally, for maximum immunological impact. Finally, the Salmonella carrier ship may be set to self-destruct in vivo once its antigen-production activities have been successfully completed. This cellular lysis occurs because the modified strains require specialized sugars available in the lab, but absent in the human body. Once the bacterium exhausts its stores of specialized sugar, it is unable to sustain the integrity of its cell wall, and bursts.
The current studies appearing in Infection and Immunity describe the latest efforts at designing effective RASV strains against tuberculosis. Using a mouse model, the group, spear-headed by the efforts of Dr. Maria Dolores Juárez-Rodríguez, demonstrated that oral immunization with an RASV strain synthesizing a fusion of protein antigens to tuberculosis provided significant protection against aerosol challenge with M. tuberculosis, comparable to immunization with M. bovis BCG administered subcutaneously.
In one of the two studies, the protective efficacy imparted by RASV vaccine strains was compared with the dose of antigen each strain expressed and delivered to the cytoplasm of host cells. RASV strains designed to engage the responses of protective T cells were shown to be highly effective, significantly reducing the quantities of M. tuberculosis bacteria in the lungs and spleens of immunized mice.
Further modification incorporating regulated delayed lysis and regulated delayed antigen synthesis improved the vaccines protective properties, outpacing the performance of the BCG vaccine. Inoculation with RASV-M. tuberculosis vaccines also acts to induce gamma interferon (IFN-) and tumor necrosis factor alpha (TNF-), important cytokines, which are implicated in controlling infection by intracellular pathogens like M. tuberculosis.
The traditional BCG vaccine, in use for over 80 years, is effective at protecting newborns and children from complications of the disease, including meningitis, but does not confer long-term protection from infection. Further, effectiveness of the BCG vaccine in adults varies considerably from 0 to 80 percent. By contrast, an orally-delivered RASV vaccine is expected to be broadly effective in populations. The Clark-Curtiss/Curtiss TB research team are continuing to develop improved RASV-M. tuberculosis systems into safe, efficacious vaccines that confer long-lasting protection against infection with M. tuberculosis.
Provided by Arizona State University
- New salmonella-based 'clean vaccines' aid the fight against infectious disease Jun 29, 2011 | not rated yet | 0
- New tuberculosis vaccine is developed Jun 06, 2007 | not rated yet | 0
- Experimental vaccine elicits robust response against both HIV and tuberculosis May 22, 2012 | not rated yet | 0
- Research identifies type of vaccine that holds promise in protecting against TB Oct 20, 2008 | not rated yet | 0
- New generation of salmonella-based, single dose vaccine candidates to fight infant pneumonia Jan 12, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0 |
Chronic obstructive pulmonary disease (COPD) is primarily associated with the respiratory symptoms that are its hallmark, but in fact, patients who struggle with the disease also experience significant amounts of chronic ...
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0
Depression is common in patients with chronic obstructive pulmonary disease (COPD) and has been linked with disease severity and impaired quality of life. Now, for the first time, researchers at the University of Pittsburgh ...
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...
Diseases, Conditions, Syndromes 2 hours ago | 5 / 5 (2) | 0 |
Clinical measurement of physical activity appears to be an independent predictor of whether or not patients with chronic obstructive pulmonary disease (COPD) will end up being hospitalized, according to a new study conducted ...
Diseases, Conditions, Syndromes 4 hours ago | not rated yet | 0
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
34 minutes ago | 4.5 / 5 (2) | 0 |
Children with autism showed significant improvement after six months of simple sensory exercises at home using everyday items such as scents, spoons and sponges, according to UC Irvine neurobiologists.
20 minutes ago | not rated yet | 0 |
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
26 minutes ago | not rated yet | 0
Overweight and obese patients are significantly more likely than their normal-weight counterparts to repeatedly switch primary care doctors, a practice that disrupts continuity of care and leads to more emergency room visits, ...
21 minutes ago | not rated yet | 0
Children who are exposed to secondhand smoke in early childhood are more likely to grow up to physically aggressive and antisocial, regardless of whether they were exposed during pregnancy or their parents have a history ...
57 minutes ago | 1 / 5 (1) | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
2 hours ago | 3.5 / 5 (2) | 0 |